Dermata Therapeutics (DRMAW) Q2 2025 Earnings

May 14Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-4.5
-3.45
-2.39
-1.34

Details

Expected EPS
-4.5
Actual EPS
-4.5
Surprise EPS
0
Surprise Percent
+0%

Description

⁨Dermata Therapeutics⁩ (⁦DRMAW⁩) has reported earnings of ⁦-4.5⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts